Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajjai S Alva

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Diabetes Care|December 1, 2010
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery: comment on Isbell et alKerem Ozer, Shadi Abdelnour, Ajjai S Alva
Frontiers in Oncology|October 24, 2022
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinomaCharles B Nguyen, Christopher T Su, Meredith Morgan, et al.
Cancer Treatment and Research Communications|December 14, 2020
Immunotherapy in metastatic sarcomatoid renal cell carcinoma: A single institution experienceJoseph J Park, Olesia Kellezi, Reema Hamasha, et al.
Nature Reviews. Urology|April 11, 2012
Perioperative chemotherapy for upper tract urothelial cancerAjjai S Alva, Surena F Matin, Seth P Lerner, et al.
Future Oncology (London, England)|March 23, 2011
Hypomethylating agents for urologic cancersAjjai S Alva, Noah M Hahn, Ana M Aparicio, et al.
Cancers|February 10, 2024
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell CarcinomaCharles B Nguyen, Eugene Oh, Piroz Bahar, et al.
Journal of Oncology Practice|August 11, 2018
Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our PracticeErica Campagnaro, Melissa A Reimers, Angel Qin, et al.
Prostate Cancer|December 23, 2011
Epigenetics in prostate cancerCostantine Albany, Ajjai S Alva, Ana M Aparicio, et al.
Oncotarget|April 16, 2020
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignanciesMatthew H Taylor, Ajjai S Alva, Timothy Larson, et al.
JCO Precision Oncology|December 21, 2023
Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic FeaturesCharles B Nguyen, Claire Knaus, Jinju Li, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Diabetes Care|December 1, 2010
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery: comment on Isbell et alKerem Ozer, Shadi Abdelnour, Ajjai S Alva
Frontiers in Oncology|October 24, 2022
Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinomaCharles B Nguyen, Christopher T Su, Meredith Morgan, et al.
Cancer Treatment and Research Communications|December 14, 2020
Immunotherapy in metastatic sarcomatoid renal cell carcinoma: A single institution experienceJoseph J Park, Olesia Kellezi, Reema Hamasha, et al.
Nature Reviews. Urology|April 11, 2012
Perioperative chemotherapy for upper tract urothelial cancerAjjai S Alva, Surena F Matin, Seth P Lerner, et al.
Future Oncology (London, England)|March 23, 2011
Hypomethylating agents for urologic cancersAjjai S Alva, Noah M Hahn, Ana M Aparicio, et al.
Cancers|February 10, 2024
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell CarcinomaCharles B Nguyen, Eugene Oh, Piroz Bahar, et al.
Journal of Oncology Practice|August 11, 2018
Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our PracticeErica Campagnaro, Melissa A Reimers, Angel Qin, et al.
Prostate Cancer|December 23, 2011
Epigenetics in prostate cancerCostantine Albany, Ajjai S Alva, Ana M Aparicio, et al.
Oncotarget|April 16, 2020
A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignanciesMatthew H Taylor, Ajjai S Alva, Timothy Larson, et al.
JCO Precision Oncology|December 21, 2023
Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic FeaturesCharles B Nguyen, Claire Knaus, Jinju Li, et al.
Pageof 6